Empowered by Data: Spotlight on Screening for Sexual Health

September 30, 2025

By

Jess Donovan, MPH, BSN


September is Sexual Health Awareness Month. As we close out September, we’re highlighting two of the measures we report on – Cervical Cancer Screening and Chlamydia Screening in Women. 

Cervical cancer, once one of the most common cancers affecting women in the United States, has significantly decreased since the 1970s. The reason for the decline can mainly be attributed to routine cervical cancer screenings, which can be done through routine Pap smears and HPV tests. 1,2 In recent years, there has also been a notable decrease in cervical cancer rates among women between the ages of 20 and 24, and is likely a result of the introduction of the HPV vaccine series. 1 While the human papillomavirus (HPV) is not the only cause of cervical cancer, it is considered the most important risk factor and accounts for nine of out ten cervical cancer cases. 3,4 HPV is a very common virus, spread through skin-to-skin contact, including sexual activity, and affects approximately 13 million people each year. 3,5 Fortunately, the HPV vaccine has been found to prevent more than 90% of cancers caused by HPV, including cervical cancer. 4,5  

Chlamydia, a common and treatable bacterial infection, is also spread through sexual contact with an infected partner. 6 Individuals can be infected with chlamydia without showing symptoms, making it difficult to diagnose on symptoms alone. 7 Additionally, repeat infections are also possible. 7 If left untreated, chlamydia can cause pelvic inflammatory disease in women, which can lead to complications such as ectopic pregnancy, infertility, and chronic pelvic/abdominal pain. 7 The most effective way to diagnose chlamydia and prevent long-term complications is through recommended urine tests or vaginal swabs. 7 Fortunately, cases have declined 8% across the United States since 2023. 8  

Measure Definitions

Both measures are stewarded by the National Committee for Quality Assurance (NCQA). Below are the measure definitions: 

  • Cervical Cancer Screening  : Assesses women who were screened for cervical cancer using any of the following criteria: 
  • Women 21-64 years of age who had cervical cytology performed within the last 3 years. 
  • Women 30-64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years. 
  • Women 30-64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) cotesting within the last 5 years. 
  • Chlamydia Screening in Women  : Percentage of persons 16-24 years of age who were recommended for routine chlamydia screening, were identified as sexually active, and had at least one test for chlamydia during the measurement period. 

What the data shows 

The data for these measures are aggregated and reported to MNCM by health plans. Analyses of these measures show: 

Cervical Cancer Screening 

  • The number of women with an up-to-date cervical cancer screening has decreased slightly in 2023 compared to 2021: 68.0% and 70.2%, respectively. 
  • Women with commercial insurance coverage had a higher rate of screening compared to women with Medicaid coverage: 71.8% and 63.8%, respectively.  

Chlamydia Screening 

  • The number of women who received a recommended chlamydia screening has increased slightly in 2023 compared to 2021: 48.4% and 47.7%, respectively. 
  • Women with Medicaid coverage had a higher rate of screening compared to women with commercial insurance coverage: 55.4% and 43.6%, respectively.  

Why This Matters

Despite the advances in cervical cancer prevention and chlamydia screening, there is still work to be done. In the case of cervical cancer screening, approximately 32% of women between the ages of 21 and 64 were missing an updated cervical cancer screening in 2023. And, even more desperate, approximately 52% of sexually active women between the ages of 16 and 24 received a recommended chlamydia screening in 2023.  

But this work does not lie solely on the shoulders of providers and health systems. Rather, a collaborative effort is needed not only to raise awareness on the importance of screening, but to also provide education on preventive efforts such as vaccination and safe sex practices. Empowering patients with data, fostering open and non-judgmental conversation, and providing community resources such as where to receive low-cost vaccines or free, confidential STI testing can be incredibly valuable.  Evidence-based knowledge is power.  

And it is important to note that while the measures discussed here are specific to female patients, sexual health is applicable to everyone – all sexes, gender identities, sexual orientations, and demographic groups. 


 Rethinking the Chlamydia Screening in Women Measure 

MNCM’s Measurement and Reporting Committee (MARC) reviewed the Chlamydia Screening in Women measure in March 2025. Members expressed concerns with the how the measure identifies sexually active patients (i.e., through use of oral contraception as a proxy), and the exclusion of male patients. Ultimately, the committee recommended that a public comment be submitted to NCQA with the recommended changes, which will be drafted in the next few months. If your organization has any specific comments related to the measure, please email publiccomment@mncm.org. 


Resources for Cervical Cancer

General Information

Resources for Chlamydia

General Information

HPV Vaccination Resources
Find vaccination resources near year.

Get Tested
Find testing resources near you.  


Sources 

  1. American Cancer Society (2025). Risk Factors for Cervical Cancer. Cervical Cancer. Retrieved from https://www.cancer.org/cancer/types/cervical-cancer/causes-risks-prevention/risk-factors.html 
  2. American Cancer Society (2025). Cervical Cancer Early Detection, Diagnosis, and Staging. Cervical Cancer. Retrieved from https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging.html 
  3. American Cancer Society (2025). Key Statistics for Cervical Cancer. About Cervical Cancer. Retrieved from https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.html 
  4. Centers for Disease Control & Prevention (2025). Cancers Caused by HPV. Human Papillomavirus (HPV). Retrieved from https://www.cdc.gov/hpv/about/cancers-caused-by-hpv.html 
  5. Centers for Disease Control & Prevention (2024). HPV Vaccination. Human Papillomavirus (HPV). Retrieved from https://www.cdc.gov/hpv/vaccines/ 
  6. Planned Parenthood. Chlamydia. Retrieved from: https://www.plannedparenthood.org/learn/stds-hiv-safer-sex/chlamydia 
  7. Centers for Disease Control & Prevention (2025). About Chlamydia. Sexually Transmitted Infections. Retrieved from https://www.cdc.gov/chlamydia/about/ 
  8. Centers for Disease Control & Prevention (2025). Sexually Transmitted Infections Surveillance, 2024 (Provisional). Sexually Transmitted Infections. Retrieved from https://www.cdc.gov/sti-statistics/annual/index.html#cdc_research_or_data_summary_findings-highlights 

Posted in Blog

Recent Posts

October 20, 2026
MINNEAPOLIS, Minn. — October 20, 2026 — MN Community Measurement (MNCM) today announced that it has completed its acquisition of Koble-MN's health information exchange (HIE) business line and the MNSHINE brand from The Koble Group. On November 1, MNCM will officially change its legal name to Minnesota Statewide Health Information Network and Exchange, known as MNSHINE. The transition follows a special joint meeting of MNCM's Board of Directors and members on October 12, at which the Board unanimously approved resolutions authorizing the acquisition, changing the organization's legal name, and establishing a new HIE Advisory Committee. Members unanimously adopted the name change and related amendments to the organization's Articles of Incorporation and Bylaws. An intentional decision to collaborate The transition is the result of an intentional decision by Minnesota health care leaders to collaborate on a health data landscape that makes sense: one that reduces redundancy, increases efficiency, and delivers needed information to those with legal authorization to receive it, where and when it is needed, without unnecessary administrative barriers. "This is not simply a merger of services. It is a deliberate choice to build the kind of health data infrastructure Minnesota deserves," said Liz Cinqueonce, President and CEO of MNCM. "For too long, organizations across our state have had to navigate duplicative systems and disconnected data. By bringing measurement and exchange together, we can reduce that burden and make sure the right information reaches the right people at the right time, with patient privacy protections firmly in place, so they can focus on improving care." The effort builds on months of work by the Executive Leadership Council, convened earlier this year by MNCM, the Minnesota Electronic Health Records Consortium, and Koble to explore how a sustainable, statewide health data utility could serve the public interest. "Minnesota is at its best when we take on difficult challenges together and align on solutions," said Mark Steffen, MD, Chair of the MNCM Board of Directors. "The Board's unanimous support reflects a shared conviction that our future depends on organizations keeping their unique strengths and missions while participating in shared infrastructure and governance. That balance is what enables greater coordination, transparency, efficiency, and impact." A trusted backbone for Minnesota's health data Minnesota's future health data ecosystem is one in which organizations retain their unique strengths and missions while participating in shared infrastructure and governance. The vision for MNSHINE is to become the health data utility, governed in the public interest with strong privacy protections and transparency, that serves as the trusted backbone connecting these efforts, ensuring data can be used more effectively to improve health, wellbeing, and outcomes for all Minnesotans. By bringing the measurement of health care quality, cost, and utilization together with the infrastructure that moves clinical data between organizations, MNSHINE will be positioned to support providers, payers, public health, researchers, policymakers, and communities alike, each within the limits of applicable law and participant agreements. The goal is healthier people, stronger communities, greater equity, better public decisions, smarter investments, and a health system that learns continuously. Continuity for HIE participants HIE services will continue without interruption. To ensure continuity of leadership and relationships, Chad Peterson, CEO of The Koble Group, has joined MNCM as Senior Vice President of HIE Services. “For HIE participants, this transition opens new possibilities,” said Peterson. “When exchange and measurement are guided by one mission, we can reduce duplication for providers and better support care coordination, while holding firm to the privacy protections patients expect. I’m proud to help lead that work, and I’m committed to making sure every participant feels supported as we grow.” MNCM has also established the HIE Advisory Committee as a standing committee of its Board of Directors. The committee continues the work of the Koble-MN Advisory Committee and will advise the Board on interoperability, participant relationships, privacy, security, data governance, and health equity. Jennifer Lamprecht of Sanford Health and Dr. Justine Mrosak of Hennepin Healthcare have been appointed to co-chair the committee, which will include consumer representatives alongside members representing a cross-section of Minnesota's health care community. Protecting patient privacy This transition changes who operates Minnesota's health information exchange. It does not change how patient information is protected or who may access it. MNSHINE will continue to operate in compliance with HIPAA and the Minnesota Health Records Act, which is among the strongest patient-consent laws in the nation, and in compliance with the participant agreements that govern how information is exchanged. Health information exchange and measurement will each remain governed by their own legal and contractual requirements, and bringing them into one organization does not change the purposes for which patient information may be used.
By Elizabeth Cinqueonce • October 19, 2026
Aligning for Impact: From Momentum to Action A 2026 Leadership Series from the MNCM Board Chair & President
By Elizabeth Cinqueonce • July 22, 2026
Aligning for Impact: From Vision to Momentum A 2026 Leadership Series from the MNCM Board Chair & President
May 27, 2026
MNCM’s President & CEO Liz Cinqueonce Joins Great Lakes Executive Leadership Council Advances Regional Collaboration and Quality Improvement
By Elizabeth Cinqueonce • May 13, 2026
MN Community Measurement Recognizes Innovation and Collaboration in Clinical Quality Measurement

Recent Comments

Archives

Categories